Literature DB >> 17008365

Life expectancy of adult liver allograft recipients in the UK.

K Barber1, J Blackwell, D Collett, J Neuberger.   

Abstract

BACKGROUND: Liver transplantation is a very successful therapy for those with end stage disease. Although there are numerous data on patient and graft survival after liver transplantation, life expectancy and possible loss of life (compared with a normal matched population) in those who survive remains unknown. AIMS: To assess the life expectancy and life years lost of adult liver allograft recipients, compared with an age and sex matched UK population to provide patients with more information and to improve the use of a scarce resource.
METHODS: Using the National Transplant Database held by UK Transplant, on over 3600 adult liver allograft recipients transplanted between 1985 and 2003, we analysed survival of all adults who survived more than six months after transplantation and compared survival after transplantation with national age and sex matched controls to assess life years lost.
RESULTS: Estimated median survival time of the analysis cohort of 2702 adult liver allograft recipients was 22.2 years (95% confidence interval 19.3-25.6), with an estimated loss of seven life years compared with an age and sex matched population.
CONCLUSIONS: Overall, female recipients have a longer life expectancy and lose fewer life years than male recipients. While younger recipients have a longer life expectancy, they also lose more life years. Those transplanted for cancer, hepatitis C virus infection, and alcoholic liver disease had the greatest loss of life years.

Entities:  

Mesh:

Year:  2006        PMID: 17008365      PMCID: PMC1856771          DOI: 10.1136/gut.2006.093195

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

Review 1.  Cardiac morbidity and mortality related to orthotopic liver transplantation.

Authors:  George Therapondos; Andrew D Flapan; John N Plevris; Peter C Hayes
Journal:  Liver Transpl       Date:  2004-12       Impact factor: 5.799

2.  The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution.

Authors:  Robert S Brown; John R Lake
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

3.  Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

Authors:  A Jain; J Reyes; R Kashyap; S F Dodson; A J Demetris; K Ruppert; K Abu-Elmagd; W Marsh; J Madariaga; G Mazariegos; D Geller; C A Bonham; T Gayowski; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

4.  Analysis of causes of death in liver transplant recipients who survived more than 3 years.

Authors:  J Pruthi; K A Medkiff; K T Esrason; J A Donovan; E M Yoshida; S R Erb; U P Steinbrecher; T L Fong
Journal:  Liver Transpl       Date:  2001-09       Impact factor: 5.799

5.  Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales.

Authors:  Ye H Oo; Bridget K Gunson; Robert J Lancashire; Kar K Cheng; James M Neuberger
Journal:  Transplantation       Date:  2005-09-27       Impact factor: 4.939

6.  Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.

Authors:  A Jain; A Marcos; J Reyes; G Mazariagos; R Kashyap; B Eghtesad; W Marsh; P Fontas; M De Vera; G Costa; K Patel; M Gadomski; T Starzl; J Fung
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

7.  Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.

Authors:  David J Mutimer; Bridget Gunson; John Chen; J Berenguer; Peter Neuhaus; D Castaing; J C Garcia-Valdecasas; M Salizzoni; Gonzalez E Moreno; Darius Mirza
Journal:  Transplantation       Date:  2006-01-15       Impact factor: 4.939

8.  Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.

Authors:  Ronald W Busuttil; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Sue V McDiarmid; Leonard I Goldstein; Sammy Saab; Steven Han; Francisco Durazo; Michael Weaver; Carlos Cao; Tony Chen; Gerald S Lipshutz; Curtis Holt; Sherilyn Gordon; Jeffery Gornbein; Farin Amersi; Rafik M Ghobrial
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

9.  Pretransplant MELD score and post liver transplantation survival in the UK and Ireland.

Authors:  Mathew Jacob; Lynn P Copley; James D Lewsey; Alex Gimson; Giles J Toogood; Mohamed Rela; Jan H P van der Meulen
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

10.  Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.

Authors:  Louise Longworth; Tracey Young; Martin J Buxton; Julie Ratcliffe; James Neuberger; Andrew Burroughs; Stirling Bryan
Journal:  Liver Transpl       Date:  2003-12       Impact factor: 5.799

  10 in total
  12 in total

1.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients.

Authors:  Fredrik Åberg
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

3.  Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience.

Authors:  Vicky L Ng; Estella M Alonso; John C Bucuvalas; Geoff Cohen; Christine A Limbers; James W Varni; George Mazariegos; John Magee; Susan V McDiarmid; Ravinder Anand
Journal:  J Pediatr       Date:  2011-12-20       Impact factor: 4.406

4.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

5.  Disseminated tuberculosis following liver transplant presenting with an axillary abscess.

Authors:  Emma Ladds
Journal:  BMJ Case Rep       Date:  2014-02-07

6.  Liver transplantation: fifty years of experience.

Authors:  Alice Tung Wan Song; Vivian Iida Avelino-Silva; Rafael Antonio Arruda Pecora; Vincenzo Pugliese; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  Evolving Role of Liver Transplantation in Elderly Recipients.

Authors:  Omar Y Mousa; Justin H Nguyen; Yaohua Ma; Bhupendra Rawal; Kaitlyn R Musto; Marjorie K Dougherty; Jefree A Shalev; Denise M Harnois
Journal:  Liver Transpl       Date:  2019-07-20       Impact factor: 5.799

8.  NKT cells are important mediators of hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Stephen M Anderton; Sarah E M Howie
Journal:  Transpl Immunol       Date:  2017-08-07       Impact factor: 1.708

9.  Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis.

Authors:  Michael J Pflüger; Max M Maurer; Karl H Hillebrandt; Andreas Andreou; Dominik Geisel; Moritz Schmelzle; Johann Pratschke; Dennis Eurich
Journal:  J Clin Exp Hepatol       Date:  2020-11-25

10.  Q-FISH measurement of hepatocyte telomere lengths in donor liver and graft after pediatric living-donor liver transplantation: donor age affects telomere length sustainability.

Authors:  Youichi Kawano; Naoshi Ishikawa; Junko Aida; Yukihiro Sanada; Naotaka Izumiyama-Shimomura; Ken-ichi Nakamura; Steven S S Poon; Koshi Matsumoto; Koichi Mizuta; Eiji Uchida; Takashi Tajiri; Hideo Kawarasaki; Kaiyo Takubo
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.